Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

19199400883_6db786ce0d_b

Price hiking: US pharma’s elephant in the room

October 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …
Feature
november_2016_front_page

The November Issue of Pharmafocus is now live!

October 26, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, features, latest news, news

The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of …
News
top_ten_1

Top Ten articles in the pharma industry this week

October 21, 2016 Medical Communications biggest stories, news, week, weekly

This week has seen a few big collaboration and partnerships occur, whilst there have been some major movements within immunotherapy …
News

Merck KGaA and Pfizer team up with Debiopharm in lung cancer treatment

October 21, 2016 Medical Communications Debiopharm, Merck KGaA, NSCLC, Pfizer, lung cancer

Debiopharm International, the Swiss-based global biopharmaceutical group of five companies, announced that it would be entering into an agreement with …
News
gilead-sciences

Gilead’s drug boosted by positive Phase II trials and aims to move forward

October 21, 2016 Medical Communications Gilead, Gilead Sciences, clinical trials, fatty liver disease

Gilead Sciences has announced positive results from three Phase II studies upon their drug GS-4997, otherwise known as selonsertib. The …
News

UK Government announces deep cuts to pharmacy funding

October 21, 2016 Medical Communications Conservative, NHS, UK, government, pharmacy

The Department Health announced that it wanted to reduce the £2.8 billion a year funding for pharmacies by 7%, leading …
News
allergan

FDA advisory committee approves of Allergan’s night-time urination medicine

October 20, 2016 Medical Communications Allergan, FDA, Night-time urination, sleep, urination

The FDA’s advisory committee ruled, in a 14-4 vote, that Allergan’s experimental nocturnal urination medication, SER120, in favour of the …
News
lilly_scientists

Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …
News
sunset-flag-america-fields

The Pharmafocus guide to the US presidential election 2016

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing US election, feature

The US presidential election is mere weeks away, and the pharmaceutical industry and drug pricing have occupied quite a large …
Feature
novartis_window

Novartis in collaboration deal worth potential $1.2 billion with Cerulean

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerulean, NDC, Novartis

Novartis has signed an agreement with Cerulean Pharma, worth a potential $1.2 billion depending on milestones met, to co-develop nanoparticle-drug …
News
celgene_1_02

Celgene’s Otezla approved by NICE for chronic plaque psoriasis

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, NICE, apremilast, otezla

NICE has given its approval to another indication for Celgene’s Otezla (apremilast), meaning NHS patients now have access to the …
News

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
News
f_44819

Oxford Genetics boosts cell/gene therapy R&D with new facility

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …
News
c_agsandrew_-_fotolia

IBM and Quest forge precision cancer treatment partnership

October 18, 2016 Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology

IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …
News

Wickham Laboratories Announces Renewal of FDA Accreditation

October 17, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now …
News
Press release
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026